• LAST PRICE
    7.9400
  • TODAY'S CHANGE (%)
    Trending Down-0.3600 (-4.3373%)
  • Bid / Lots
    7.4200/ 4
  • Ask / Lots
    8.2300/ 10
  • Open / Previous Close
    8.2700 / 8.3000
  • Day Range
    Low 7.2778
    High 8.2900
  • 52 Week Range
    Low 1.6200
    High 9.0000
  • Volume
    741,662
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 8.3
TimeVolumeTCRX
09:32 ET129057.61
09:34 ET93067.335
09:36 ET47637.63
09:38 ET4007.75
09:39 ET2007.8727
09:41 ET1007.7696
09:43 ET29797.99
09:45 ET2007.97
09:48 ET7157.8
09:50 ET3007.97
09:52 ET22708.1
09:54 ET1008.15
09:56 ET7508.17
09:57 ET36358.145
09:59 ET2008.13
10:01 ET2008.05
10:03 ET2008.125
10:06 ET5008.225
10:08 ET2008.205
10:10 ET5008.09
10:12 ET7008.11
10:14 ET2008.11
10:15 ET2008.04
10:17 ET2008.07
10:19 ET2508.07
10:24 ET1008.07
10:26 ET5008.13
10:28 ET3008.07
10:30 ET1008.07
10:33 ET8088.065
10:35 ET1008.04
10:39 ET4008.06
10:42 ET1008
10:46 ET3008.005
10:50 ET1008
10:53 ET2008
10:55 ET1008
11:02 ET2008
11:04 ET1008.06
11:08 ET2008
11:09 ET7567.99
11:11 ET2008
11:13 ET3007.961
11:18 ET7157.9616
11:20 ET2008.015
11:22 ET1008.0425
11:24 ET2007.97
11:26 ET1007.96
11:27 ET4008.01
11:31 ET16498.06
11:33 ET17958.06
11:38 ET1008.045
11:40 ET2008
11:42 ET18197.95
11:44 ET1007.95
11:49 ET6007.94
11:51 ET1007.955
11:54 ET10477.92
11:56 ET62577.69
11:58 ET3457.7
12:00 ET1007.73
12:02 ET2477.735
12:03 ET15147.86
12:05 ET14007.92
12:07 ET13067.99
12:09 ET2008
12:14 ET4007.96
12:16 ET9008.01
12:18 ET1008.01
12:20 ET17567.92
12:21 ET1007.97
12:23 ET1007.94
12:25 ET4777.96
12:27 ET1008.01
12:32 ET40957.96
12:36 ET35227.945
12:38 ET3007.97
12:39 ET30237.945
12:43 ET1007.945
12:45 ET1257.945
12:48 ET5727.96
12:50 ET7787.9303
12:52 ET1007.93
12:54 ET1007.93
12:56 ET4127.94
12:57 ET20827.91
12:59 ET6337.9
01:01 ET11957.86
01:12 ET9087.86
01:14 ET3007.86
01:15 ET1007.855
01:17 ET5177.905
01:19 ET7007.91
01:24 ET2507.955
01:26 ET1007.96
01:28 ET1007.92
01:32 ET1007.935
01:33 ET25557.96
01:35 ET2007.96
01:37 ET1007.995
01:39 ET16547.88
01:42 ET2007.825
01:46 ET3007.87
01:48 ET12327.88
01:50 ET4007.96
01:55 ET2007.95
02:00 ET4947.955
02:02 ET3007.98
02:04 ET2007.985
02:06 ET6007.96
02:08 ET28357.94
02:09 ET1007.91
02:11 ET2007.915
02:15 ET6407.945
02:18 ET12037.86
02:20 ET3007.875
02:22 ET2007.92
02:24 ET10007.94
02:26 ET9667.92
02:27 ET8777.94
02:29 ET3007.9493
02:31 ET1007.96
02:33 ET6427.95
02:40 ET6367.89
02:42 ET22027.9
02:44 ET1007.9
02:45 ET1007.88
02:47 ET4007.91
02:49 ET15547.94
02:56 ET1007.98
02:58 ET16007.98
03:00 ET10007.965
03:02 ET4417.93
03:03 ET1007.95
03:07 ET1007.91
03:09 ET1007.92
03:12 ET12677.93
03:16 ET8027.925
03:18 ET1007.925
03:20 ET3007.92
03:21 ET2007.87
03:25 ET5007.89
03:27 ET1007.89
03:30 ET13367.885
03:32 ET7837.81
03:34 ET10167.79
03:36 ET3437.76
03:38 ET2007.765
03:39 ET3007.7899
03:41 ET6007.73
03:43 ET9007.725
03:45 ET21117.79
03:48 ET2007.8
03:50 ET10007.77
03:52 ET33697.8571
03:54 ET43897.92
03:56 ET48117.94
03:57 ET13007.93
03:59 ET51507.94
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTCRX
TScan Therapeutics Inc
380.2M
-3.2x
---
United StatesMGTX
MeiraGTx Holdings PLC
386.1M
-3.8x
---
United StatesACIU
AC Immune SA
293.6M
-4.2x
---
United StatesABUS
Arbutus Biopharma Corp
463.1M
-5.9x
---
United StatesHOWL
Werewolf Therapeutics Inc
276.9M
-6.2x
---
United StatesMESO
Mesoblast Ltd
412.5M
-3.5x
---
As of 2024-03-29

Company Information

TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. The Company’s lead TCR-T therapy candidates, TSC-100 and TSC-101, are in clinical development for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. The Company is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. The Company has developed and continues to build its ImmunoBank, a collection of solid tumor targets across different Human leukocyte antigens (HLAs) types in the TCR field. The Company is advancing approximately six solid tumor programs: TSC-204, TSC-200, TSC-203, TSC-201, TSC-202 and TSC-205.

Contact Information

Headquarters
880 Winter StreetWALTHAM, MA, United States 02451
Phone
857-399-9500
Fax
302-531-3150

Executives

Non-Executive Independent Chairman
Timothy Barberich
Chief Executive Officer
Gavin Macbeath
Principal Financial Officer, Principal Accounting Officer, Treasurer
Jason Amello
Senior Vice President - Human Resources
Ann Hargraves
Senior Vice President - Medical, Translational Medicine
Shrikanta Chattopadhyay

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$380.2M
Revenue (TTM)
$21.0M
Shares Outstanding
47.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.49
Book Value
$3.15
P/E Ratio
-3.2x
Price/Sales (TTM)
18.1
Price/Cash Flow (TTM)
---
Operating Margin
-444.00%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.